Загрузка...

Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression

Lurasidone is a novel antipsychotic agent approved for the treatment of schizophrenia in a number of countries including the UK, and is also approved in the USA and Canada for the treatment of major depressive episodes associated with bipolar I disorder as either a monotherapy or adjunctive therapy...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BJPsych Bull
Главные авторы: Loebel, Antony, Citrome, Leslie
Формат: Artigo
Язык:Inglês
Опубликовано: Royal College of Psychiatrists 2015
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706192/
https://ncbi.nlm.nih.gov/pubmed/26755968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/pb.bp.114.048793
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!